(Q44133182)

30 November 2017

1 reference

title

Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a review of diagnosis and management (English)

1 reference

30 November 2017

1 reference

C J Saphier

1

1 reference

PubMed ID

9638906

30 November 2017

J T Repke

series ordinal

2

1 reference

30 November 2017

1 April 1998

1 reference

30 November 2017

Seminars in Perinatology

1 reference

30 November 2017

22

1 reference

30 November 2017

2

1 reference

30 November 2017

118-133

1 reference

Hematologic assays in pre-eclampsia

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Pregnancy-induced hypertension complicated by acute liver disease and disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Pregnancy-induced hypertension presenting with life-threatening thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Hematologic evidence of disseminated intravascular coagulation in eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Severe edema-proteinuria-hypertension gestosis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Plasma exchange for preeclampsia. I. Postpartum use for persistently severe preeclampsia-eclampsia with HELLP syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

The natural history of HELLP syndrome: patterns of disease progression and regression

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Liver disease in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Liver disease in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy: review of 11 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Thrombotic thrombocytopenic purpura: report of fourteen cases--occurrence during pregnancy and response to plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

The intrapartum platelet count in patients with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome: is it predictive of later hemorrhagic complications?

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Maternal hemolysis, elevated liver enzymes, low platelet count, and neonatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Maternal haemolysis, elevated liver enzymes and low platelets syndrome: specific problems in the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Spontaneous resolution of pre-eclampsia-related thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count).

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Corticosteroids for the enhancement of fetal lung maturity: impact on the gravida with preeclampsia and the HELLP syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Thrombocytopenia in preeclampsia: associated abnormalities and management principles

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Temporising management of severe pre-eclampsia with and without the HELLP syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Treatment of persistent postpartum HELLP syndrome with plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Plasma exchange for preeclampsia: II. Unsuccessful antepartum utilization for severe preeclampsia with or without HELLP syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Corticosteroids for enhanced fetal lung maturation in patients with HELLP syndrome: impact on neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP).

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

A protocol for managing severe preeclampsia in the second trimester

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Daily antenatal testing in women with severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

An abnormal umbilical artery waveform: a strong and independent predictor of adverse perinatal outcome in patients with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Clinical indications for pulmonary artery catheterization in the patient with severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Factors relevant to mode of preterm delivery with syndrome of HELLP (hemolysis, elevated liver enzymes, and low platelets)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Postoperative incision complications after cesarean section in patients with antepartum syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP): does delayed primary closure make a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Haemolytic uraemic syndrome in women taking oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

The haemolytic uraemic syndrome and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Thrombotic thrombocytopenic purpura associated with oral contraceptives: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Reversal of long-standing renal insufficiency by captopril in a patient with relapsing hemolytic uremic syndrome due to an oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Oral contraception as a risk factor for preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Prevention of Preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Trial of calcium to prevent preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Calcium supplementation during pregnancy: a systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980044-X

7 January 2021

10.1016/S0146-0005(98)80044-X

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

9638906